335
Views
7
CrossRef citations to date
0
Altmetric
Letter to the Editor

Successful Tocilizumab Treatment for Scleritis

, &
Pages 285-287 | Received 19 Feb 2019, Accepted 08 May 2019, Published online: 14 Aug 2019

References

  • Erdogan M, Sayin N, Yildiz Ekinci D, Bayramoglu S. Bilateral posterior scleritis associated with giant cell arteritis: A case report. Ocul Immunol Inflamm. 2017;15:1–4.
  • Cavallini GM, Volante V, Bigliardi MC, Mascia MT, Forlini M. Bilateral posterior scleritis as a presenting manifestation of giant cell arteritis: A case report. Can J Ophthalmol. 2014;49:141–143. doi:10.1016/j.jcjo.2013.10.004.
  • Stone JH, Tuckwell K, Dimonaco S, et al. Trial of tocilizumab in giant-cell arteritis. N Engl J Med. 2017;377:317–328. doi:10.1056/NEJMoa1613849.
  • Sammel AM, Fraser CL. Update on giant cell arteritis. Curr Opin Ophthalmol. 2018;29:520–527. doi:10.1097/ICU.0000000000000528.
  • Sainz-de-la-Maza M, Molins B, Mesquida M, et al. Interleukin-22 serum levels are elevated in active scleritis. Acta Ophthalmol. 2016;94:395–399. doi:10.1111/aos.13005.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.